SCHEMBL23723347

SCHEMBL23723347

O=C(O)NCC=C(F)CSc1cccc(CO)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
APEX1 P27695 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 2/20 0.34
POLB P06746 1/20 0.34
FFAR1 O14842 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23723345 1.00 ALDH1A1 (0.41) ALDH1A1APEX1SMN1; SMN2GAAPOLB
SCHEMBL23723269 0.85 KMT2A (0.41) ALDH1A1APEX1SMN1; SMN2GAAPOLB
SCHEMBL23723267 0.85 KMT2A (0.41) ALDH1A1APEX1SMN1; SMN2GAAPOLB
SCHEMBL23723321 0.84 APEX1 (0.38) ALDH1A1APEX1SMN1; SMN2GAAPOLB
SCHEMBL23723322 0.84 APEX1 (0.38) ALDH1A1APEX1SMN1; SMN2GAAPOLB
SCHEMBL23723341 0.83 ALDH1A1 (0.36) ALDH1A1APEX1SMN1; SMN2GAAPOLB
SCHEMBL23745972 0.83 ALDH1A1 (0.36) ALDH1A1POLBKDM4ETSHRATM
SCHEMBL23723344 0.83 ALDH1A1 (0.36) ALDH1A1APEX1SMN1; SMN2GAAPOLB
SCHEMBL21646305 0.75 GAA (0.40) ALDH1A1SMN1; SMN2GAAPOLBKDM4E
SCHEMBL21646304 0.75 GAA (0.40) ALDH1A1SMN1; SMN2GAAPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230349907-A1 BIOPROBES FOR LYSYL OXIDASES AND USES THEREOF PHARMAXIS LTD. (AU) 2023-11-02 US disclosed
WO-2021155439-A1 BIOPROBES FOR LYSYL OXIDASES AND USES THEREOF PHARMAXIS LTD. (AU) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230349907-A1 BIOPROBES FOR LYSYL OXIDASES AND USES THEREOF MAOB, LOX, LPO ALDH1A1 367/4885APEX1 298/4885SMN1; SMN2 4690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.